Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'

Ann Rheum Dis. 2023 Jun;82(6):e130. doi: 10.1136/annrheumdis-2021-220148. Epub 2021 Mar 10.
No abstract available

Keywords: COVID-19; autoimmune diseases; rituximab.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Viral
  • Antibody Formation
  • Autoimmune Diseases*
  • COVID-19*
  • Humans
  • Rheumatic Diseases* / complications
  • Rituximab
  • SARS-CoV-2

Substances

  • Rituximab
  • Antibodies, Viral